US Patent Issued to R L FINECHEM on Sept. 29 for "Method for preparation of 1-(2-((2,4-dimethylphenyl)thio)phenyl) piperazine and its salts" (Indian Inventors)

Posted On: 2026-09-30

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,220, issued on Sept. 29, was assigned to R L FINECHEM PRIVATE Ltd. (Bangalore, India). "Method for preparation of 1-(2-((2,4-dimethylpheny... Read More

US Patent Issued to Emory Univeristy, Neurop on Sept. 29 for "GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pH" (Georgia Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,221, issued on Sept. 29, was assigned to Emory Univeristy (Atlanta) and Neurop Inc. (Atlanta). "GluN2B-subunit selective antagonists of th... Read More

US Patent Issued to Ramot at Tel-Aviv University, The Board of Trustees of the Leland Stanford Junior University on Sept. 29 for "Chemiluminescence probes for tuberculosis" (Israeli, American Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,222, issued on Sept. 29, was assigned to Ramot at Tel-Aviv University Ltd. (Tel Aviv, Israel) and The Board of Trustees of the Leland Stanf... Read More

US Patent Issued to AstraZeneca on Sept. 29 for "N-(2-(3-cyano-2-azabicyclo[3.1.0hexan-2-yl)-2-oxoethyl)quinoline-4-carboxamides" (Swedish Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,223, issued on Sept. 29, was assigned to AstraZeneca AB (Sodertalje, Sweden). "N-(2-(3-cyano-2-azabicyclo[3.1.0hexan-2-yl)-2-oxoethyl)quin... Read More

US Patent Issued to PHILOCHEM on Sept. 29 for "Fibroblast activation protein ligands for targeted delivery applications" (Swiss Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,224, issued on Sept. 29, was assigned to PHILOCHEM AG (Otelfingen, Switzerland). "Fibroblast activation protein ligands for targeted deliv... Read More

US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on Sept. 29 for "LZK-targeting degraders and methods of use" (Maryland Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,225, issued on Sept. 29, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Serv... Read More

US Patent Issued to Rigel Pharmaceuticals on Sept. 29 for "Method of preparing Pralsetinib" (Dutch, American Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,226, issued on Sept. 29, was assigned to Rigel Pharmaceuticals Inc. (South San Francisco, Calif.). "Method of preparing Pralsetinib" was i... Read More

US Patent Issued to OHIO STATE INNOVATION FOUNDATION;, THE BRIGHAM AND WOMEN'S HOSPITAL on Sept. 29 for "EAAT2 activators and methods of using thereof" (Massachusetts, Ohio Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,227, issued on Sept. 29, was assigned to OHIO STATE INNOVATION FOUNDATION; (Columbus, Ohio) and THE BRIGHAM AND WOMEN'S HOSPITAL INC. (Bost... Read More

US Patent Issued to DANA-FARBER CANCER INSTITUTE on Sept. 29 for "Potent and selective inhibitors of IRAK4" (Massachusetts Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,228, issued on Sept. 29, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston). "Potent and selective inhibitors of IRAK4" was invent... Read More

US Patent Issued to Purdue Research Foundation on Sept. 29 for "Pyrazolyl pyrimidinone compounds and the uses thereof" (Indiana, Massachusetts Inventors)

Posted On: 2026-09-30

Government News US Fed News Patentwipo

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,229, issued on Sept. 29, was assigned to Purdue Research Foundation (West Lafayette, Ind.). "Pyrazolyl pyrimidinone compounds and the uses... Read More

Exclusive

Category

Source

Publication

Byline

Location

US Patent Issued to R L FINECHEM on Sept. 29 for "Method for preparation of 1-(2-((2,4-dimethylphenyl)thio)phenyl) piperazine and its salts" (Indian Inventors)

US Patent Issued to Emory Univeristy, Neurop on Sept. 29 for "GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pH" (Georgia Inventors)

US Patent Issued to Ramot at Tel-Aviv University, The Board of Trustees of the Leland Stanford Junior University on Sept. 29 for "Chemiluminescence probes for tuberculosis" (Israeli, American Inventors)

US Patent Issued to AstraZeneca on Sept. 29 for "N-(2-(3-cyano-2-azabicyclo[3.1.0hexan-2-yl)-2-oxoethyl)quinoline-4-carboxamides" (Swedish Inventors)

US Patent Issued to PHILOCHEM on Sept. 29 for "Fibroblast activation protein ligands for targeted delivery applications" (Swiss Inventors)

US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on Sept. 29 for "LZK-targeting degraders and methods of use" (Maryland Inventors)

US Patent Issued to Rigel Pharmaceuticals on Sept. 29 for "Method of preparing Pralsetinib" (Dutch, American Inventors)

US Patent Issued to OHIO STATE INNOVATION FOUNDATION;, THE BRIGHAM AND WOMEN'S HOSPITAL on Sept. 29 for "EAAT2 activators and methods of using thereof" (Massachusetts, Ohio Inventors)

US Patent Issued to DANA-FARBER CANCER INSTITUTE on Sept. 29 for "Potent and selective inhibitors of IRAK4" (Massachusetts Inventors)

US Patent Issued to Purdue Research Foundation on Sept. 29 for "Pyrazolyl pyrimidinone compounds and the uses thereof" (Indiana, Massachusetts Inventors)